onc Videos

Videos

Anup Kasi, MD, University of Kansas Cancer Center

Videos

Neoadjuvant Treatment Options for MSI-High Gastroesophageal Junction Cancers

04/12/2023

At the 2023 GDU GI meeting, Anup Kasi, MD, participating in a debate on treatment options for patients with microsatellite instability-high locally resectably gastric or gastroesophageal junction adenocarcinoma.

At the 2023 GDU GI meeting, Anup...

04/12/2023

Oncology

Milind Javle, MD, MD Anderson Cancer Center

Videos

The Changing Treatment Landscape of Cholangiocarcinoma

04/12/2023

At the 2023 Great Debates and Updates in GI Malignancies, Milind Javle, MD, discusses the recent developments in the treatment of patients with cholangiocarcinoma.

At the 2023 Great Debates and...

04/12/2023

Oncology

Sarah Lee, MD, NYU Langone Health, New York, NY

Videos

Effect of TMB, MSI-H, and MMR Status on Clinical Outcomes in Endometrial Cancer

04/06/2023

Sarah Lee, MD, presents data at the SGO Annual Meeting on Women’s Cancers examining the effect high tumor mutational burden, high microsatellite stability, and mismatch repair deficiency may have on clinical outcomes of patients with...

Sarah Lee, MD, presents data at...

04/06/2023

Oncology

Videos

Recent Approvals for Cholangiocarcinoma Treatment

04/06/2023

While at the 2023 Great Debates and Updates in GI Malignancies meeting in Chicago, Milind Javle, MD, reviews the latest FDA approvals in the cholangiocarcinoma space.

While at the 2023 Great Debates...

04/06/2023

Oncology

Mansoor Raza Mirza, MD, Copenhagen University Hospital, Denmark

Videos

First-Line Dostarlimab Plus Chemotherapy for Endometrial Cancer

04/06/2023

At the SGO Annual Meeting on Women’s Cancer, Mansoor Raza Mirza, MD, presents the results of the ENGOT-EN6-NSGO/GOG-3031/RUBY trial, investigating the efficacy of dostarlimab plus chemotherapy in the first line for endometrial cancer.

At the SGO Annual Meeting on...

04/06/2023

Oncology

Videos

Prognostic Value of Cutaneous Disease Severity Estimates for Chronic Graft-Versus-Host Disease

04/05/2023

Emily Baumrin, MD, shares research on the value of cutaneous disease severity estimates in predicting survival outcomes in patients with chronic GVHD.

Emily Baumrin, MD, shares...

04/05/2023

Oncology

Joyce Barlin, MD, Women’s Cancer Care Associates, Albany, NY

Videos

Chemotherapy and Radiation Sandwich Therapy vs Standard of Care for Advanced Endometrial Cancer

04/05/2023

Joyce Barlin, MD, presents data from the Lunchbox trial at the SGO Annual Meeting on Women’s Cancer, comparing chemotherapy and radiation sandwich therapy vs chemotherapy alone for patients with advanced endometrial cancer.

Joyce Barlin, MD, presents data...

04/05/2023

Oncology

Videos

High-Grade Urothelial Carcinoma With Deep Muscle Invasion

04/05/2023

Matt Galsky, MD, discusses the course of treatment he would take for a patient with high-grade urothelial carcinoma with deep muscle invasion.

Matt Galsky, MD, discusses the...

04/05/2023

Oncology

Videos

The Role of Genetics in the Management of Patients with Gastrointestinal Cancer

04/01/2023

At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.

At the 2023 Great Debates &...

04/01/2023

Oncology

Anjee Davis, MPPA, Fight Colorectal Cancer

Videos

The Importance of Patient Advocacy

04/01/2023

At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, President of Fight Colorectal Cancer, Anjee Davis, MPPA, shares the importance of patient advocacy and how clinicians can help support and empower their patients...

At the 2023 Great Debates &...

04/01/2023

Oncology

Recent News

News

Pembrolizumab Plus Gemcitabine-Platinum Doublet Chemotherapy Improves Survival Regardless of Platinum Agent for Urothelial Carcinoma

11/19/2024

Stephanie Holland ;

Subset analysis results from the phase 3 KEYNOTE-361 study demonstrated that the addition of pembrolizumab to gemcitabine-platinum doublet chemotherapy improved survival for patients with advanced or metastatic urothelial carcinoma,...

Subset analysis results from the...

11/19/2024

Oncology

News

Addition of Toripalimab to First-Line Chemotherapy Improves Survival for Patients With Extensive-Stage Small Cell Lung Cancer

11/19/2024

Stephanie Holland ;

Results from the phase 3 EXTENTORCH trial demonstrated that the addition of toripalimab to first-line chemotherapy significantly improved survival among patients with extensive-stage small cell lung cancer.

Results from the phase 3...

11/19/2024

Oncology

News

Adjuvant Chemotherapy Followed by Radiation May Benefit Patients With High-Risk Endometrial Cancer

11/19/2024

Allison Casey ;

According to a phase 2 trial, adjuvant docetaxel-cisplatin followed by radiation therapy may benefit patients with high-risk endometrial cancer.

According to a phase 2 trial,...

11/19/2024

Oncology

News

Robotic Laparoscopy May Have Easier Recovery For Patients With Early-Stage, Low Risk Endometrial Cancer

11/19/2024

Allison Casey ;

According to a randomized clinical trial, there may be benefits to inflammation processes, tissue damage, stress and recovery time with robotic laparoscopy for early-stage endometrial cancer compared to conventional laparoscopy.

According to a randomized...

11/19/2024

Oncology

News

UGN-102 Chemoablation as TURBT Alternative for Patients With Recurrent Low-Grade Non-Muscle Invasive Bladder Cancer

11/19/2024

Stephanie Holland ;

According to results from the phase 3 ENVISION trial, chemoablation with UGN-102 demonstrates clinical promise as an alternative to standard-of-care transurethral resection of the bladder tumor for patients with recurrent low-grade...

According to results from the...

11/19/2024

Oncology

News

Tumor Mutational Status May Predict Recurrence, Survival Patterns for Patients With Early-Stage Non-Small Cell Lung Cancer

11/18/2024

Stephanie Holland ;

According to results from a retrospective analysis, tumor mutational status can potentially predict recurrence and survival patterns for patients with surgically resected, stage I non-small cell lung cancer.

According to results from a...

11/18/2024

Oncology

News

FDA Grants Approval to Revumenib for Patients With R/R Acute Leukemia With KMT2A Translocation

11/17/2024

On November 15, 2024, the FDA approved menin inhibitor revumenib for adult and pediatric patients 1 year and older with relapsed/refractory acute leukemia with KMT2A translocation.

On November 15, 2024, the FDA...

11/17/2024

Oncology

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology